Skip to content
Events

Details

Illumina is a proud sponsor of ICHG 2023 and we look forward to seeing you in Cape Town between 22-26 February 2023.​

We are excited to bring our most powerful and most sustainable sequencer yet, the NovaSeq™ X Plus, to Cape Town and invite you to visit our booth to speak to our experts about how it could support your projects.

Join Illumina’s session in the main agenda, ‘Diversity for the future of Precision Medicine & Health Population Screening’ chaired by Vicky Nembaware, University of Cape Town. 

Date: Friday 24 February 2023
Time: 11:00-12:30 
https://www.ichg2023.com/programme/

Date & Time
22 Feb 2023 – 26 Feb 2023
08:00 AM - 06:15 PM
Location
CTICC, Cape Town
South Africa
Topic
Oncology, Precision Health, Reproductive Health, Genetic & Rare Diseases
This event has passed

Related Events

Apr 26
NHS Wales Cancer Network Genomics Education Event 2024
26 Apr 2024
Illumina will be exhibiting at NHS Wales Cancer Network's Genomics Education Event, 26th April 2024 in Cardiff, Wales. Come and visit us at our booth, where you can meet our expert team to learn about our solutions and services on offer and discuss any requirements you may have.
View Event
May 1
Rady’s Frontiers in Pediatric Genomic Medicine Conference 2024
1 May 2024 – 2 May 2024
Learn about the latest in using rapid whole-genome sequencing for saving critically ill infants and the promise of genomic sequencing in newborn screening.
View Event
May 14
PMMP (Italian group of molecular pathology and Predictive medecine)
14 May 2024 – 16 May 2024
Illumina will be exhibiting at PMMP (Italian group of molecular pathology and Predictive medecine) 14th - 16th May
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.